2005P-0411 | Seeking FDA Actions to Counter Flagrant Violations of the Law by Pharmacies Compounding Bio-Identical Hormone Replacement Therapy Drugs | |||||||||||||||||||||||
FDA Comment Number : | EC1676 | |||||||||||||||||||||||
Submitter : | Ms. Shaista Fadra | Date & Time: | 02/13/2006 01:02:51 | |||||||||||||||||||||
Organization : | Ms. Shaista Fadra | |||||||||||||||||||||||
Category : | Individual Consumer | |||||||||||||||||||||||
Issue Areas/Comments | ||||||||||||||||||||||||
GENERAL | ||||||||||||||||||||||||
GENERAL | ||||||||||||||||||||||||
Bioidentical hormones, particularly of the non-synthetic variety, are essential in maintaining hormonal balance such as estrogen and testosterone while avoiding the potential side effects of synthetic hormones. | ||||||||||||||||||||||||